Naratriptan Tablet
Product Images NDC 0054-0278

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naratriptan (NDC 0054-0278). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of Naratriptan hydrochloride, showing the molecular framework including a sulfonamide group attached to an indole core and a methylated piperidine ring.*

FDA Label Image

\\eu.boehringer.com\depts\col\groups\dra-ma\labeling\xml Files\naratriptan HCl Tabs\labels\naratriptan Figure 1.jpg (Image 02)

Line graph showing the estimated probability of response over time in minutes from the initial dose for Naratriptan tablets at 1 mg and 2.5 mg doses compared to placebo. The vertical axis represents probability of response (0%-100%), and the horizontal axis represents time (0 to 240 minutes). Data points for placebo, 1 mg, and 2.5 mg doses are marked with different symbols and connected by lines.*

FDA Label Image

\\eu.boehringer.com\depts\col\groups\dra-ma\labeling\xml Files\naratriptan HCl Tabs\labels\naratriptan Figure 2.jpg (Image 03)

A line graph showing the estimated probability of remediation or rescue over 24 hours from the initial dose for placebo, 1 mg, and 2.5 mg doses of Naratriptan. The y-axis represents probability from 0% to 100%, and the x-axis shows time in hours. Three lines illustrate outcomes for placebo (N=395), 1 mg (N=491), and 2.5 mg (N=493) doses.*

FDA Label Image

Image 04

Naratriptan Tablets, USP 1 mg oral tablets. The label shows packaging for 9 tablets. It includes the NDC number 0054-0278-03 and is distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. The label instructs pharmacists to dispense with attached Patient Information and notes the storage temperature of 20° to 25°C (68° to 77°F).*

FDA Label Image

Image 05

Naratriptan Tablets, USP 2.5 mg oral tablets label from Hikma Pharmaceuticals USA Inc. The label lists the NDC 0054-0279-03, indicates a package of 9 tablets, and includes usage storage instructions and pharmacist dispensing information. The dosage strength is prominently highlighted in pink.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.